<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">39317224</PMID><DateCompleted><Year>2024</Year><Month>09</Month><Day>24</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>21</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1678-4227</ISSN><JournalIssue CitedMedium="Internet"><Volume>82</Volume><Issue>9</Issue><PubDate><Year>2024</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Arquivos de neuro-psiquiatria</Title><ISOAbbreviation>Arq Neuropsiquiatr</ISOAbbreviation></Journal><ArticleTitle>Impact on the nervous system of long COVID-19 infection in children.</ArticleTitle><Pagination><StartPage>1</StartPage><EndPage>7</EndPage><MedlinePgn>1-7</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1055/s-0044-1789224</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">&#x2003;The coronavirus disease 2019 (COVID-19) pandemic has had a profound global impact, raising concerns about its long-term effects, particularly neurological complications. While studies have highlighted such complications in adults, there is a paucity of research focusing on children.</AbstractText><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">&#x2003;To examine the medium- to long-term neurological and cognitive symptoms in 18 year old children and below with positive versus negative COVID-19 antigens and to identify the probable risk factors to promote specific health actions.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">&#x2003;An observational study was carried out to determine neurological symptoms in the medium and long terms after COVID 19. A random sample of 124 children, both symptomatic or asymptomatic, tested positive or negative for COVID-19 through swab tests.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">&#x2003;Neurological symptoms were assessed between 6 to 12 months and 2 years after the infection. Acute symptoms, including headache, anosmia, ageusia, and myalgia, were observed in more than 20% of the children, but they generally resolved within 6 to 12 months. Persistent functional difficulties, such as in studying, paying attention, and socializing, were reported in 3% of the cases. Behavioral symptoms at baseline were noted in 7.8% of children, but they were remitted in most cases, except for those with prior involvement.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">&#x2003;These findings underscore the need for continued monitoring of children following COVID-19 infection and the importance of tailored health interventions.</AbstractText><CopyrightInformation>The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution 4.0 International License, permitting copying and reproduction so long as the original work is given appropriate credit (https://creativecommons.org/licenses/by/4.0/).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Granana</LastName><ForeName>Nora</ForeName><Initials>N</Initials><Identifier Source="ORCID">0000-0002-8448-2611</Identifier><AffiliationInfo><Affiliation>Hospital General de Agudos Carlos G. Durand, Departmento de Pediatr&#xed;a, Buenos Aires, Argentina.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Ministerio de Salud, Programa de Orientaci&#xf3;n Temprana y Concientizaci&#xf3;n de Trastornos del Desarrollo y en el Espectro Autista, Buenos Aires, Argentina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tarulla</LastName><ForeName>Adriana</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-3605-6087</Identifier><AffiliationInfo><Affiliation>Ministerio de Salud, Programa de Neurociencias, Buenos Aires, Argentina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Calandri</LastName><ForeName>Ismael</ForeName><Initials>I</Initials><Identifier Source="ORCID">0000-0002-6983-1430</Identifier><AffiliationInfo><Affiliation>Ministerio de Salud, Programa de Neurociencias, Buenos Aires, Argentina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Carli</LastName><ForeName>Analia De</ForeName><Initials>A</Initials><Identifier Source="ORCID">0009-0008-2668-5155</Identifier><AffiliationInfo><Affiliation>Hospital Ramos Mej&#xed;a, Programa de Salud Escolar, Buenos Aires, Argentina.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Ministerio de Salud, Programa de Salud Escolar, Buenos Aires, Argentina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rivas</LastName><ForeName>Belen</ForeName><Initials>B</Initials><Identifier Source="ORCID">0000-0003-3655-9925</Identifier><AffiliationInfo><Affiliation>Hospital Ramos Mej&#xed;a, Programa de Salud Escolar, Buenos Aires, Argentina.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Ministerio de Salud, Programa de Salud Escolar, Buenos Aires, Argentina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Festa</LastName><ForeName>Jose Maria</ForeName><Initials>JM</Initials><Identifier Source="ORCID">0009-0008-6304-9086</Identifier><AffiliationInfo><Affiliation>Hospital Ramos Mej&#xed;a, Programa de Salud Escolar, Buenos Aires, Argentina.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Ministerio de Salud, Programa de Salud Escolar, Buenos Aires, Argentina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vacirca</LastName><ForeName>Susana</ForeName><Initials>S</Initials><Identifier Source="ORCID">0009-0005-4398-5043</Identifier><AffiliationInfo><Affiliation>Ministerio de Salud, Programa de Salud Escolar, Buenos Aires, Argentina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lis</LastName><ForeName>Mar&#xed;a</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-3628-336X</Identifier><AffiliationInfo><Affiliation>Hospital General de Agudos Carlos G. Durand, Departmento de Pediatr&#xed;a, Buenos Aires, Argentina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Worff</LastName><ForeName>Iris</ForeName><Initials>I</Initials><Identifier Source="ORCID">0009-0006-2252-3680</Identifier><AffiliationInfo><Affiliation>Ministerio de Salud, Hospital de Emergencias Psiqui&#xe1;tricas Torcuato de Alvear, Departamento de Salud Mental, Buenos Aires, Argentina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Allegri</LastName><ForeName>Ricardo</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0001-7166-1234</Identifier><AffiliationInfo><Affiliation>Ministerio de Salud, Programa de Neurociencias, Buenos Aires, Argentina.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D064888">Observational Study</PublicationType></PublicationTypeList><VernacularTitle>Impacto en el sistema nervioso de la infecci&#xf3;n COVID-19 larga en ni&#xf1;os.</VernacularTitle><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Arq Neuropsiquiatr</MedlineTA><NlmUniqueID>0125444</NlmUniqueID><ISSNLinking>0004-282X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009422" MajorTopicYN="N">Nervous System Diseases</DescriptorName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading></MeshHeadingList><OtherAbstract Type="Publisher" Language="por"><AbstractText Label="ANTECEDENTES" NlmCategory="BACKGROUND">&#x2003;La pandemia por enfermedad por coronavirus 2019 (<i>coronavirus disease 2019</i>, COVID-19, en ingl&#xe9;s) ha tenido un profundo impacto global y ha generado preocupaci&#xf3;n sobre sus efectos a largo plazo, especialmente sobre las complicaciones neurol&#xf3;gicas. Si bien los estudios han destacado tales complicaciones en adultos, hay escasez de investigaciones centradas en ni&#xf1;os.</AbstractText><AbstractText Label="OBJETIVO" NlmCategory="OBJECTIVE">&#x2003;Examinar los s&#xed;ntomas neurol&#xf3;gicos y cognitivos a mediano y largo plazo en ni&#xf1;os de 18 a&#xf1;os o menos, con ant&#xed;genos positivos <i>versus</i> negativos para COVID-19, e identificar los posibles factores de riesgo para promover acciones de salud espec&#xed;ficas. M&#xe9;TODOS: &#x2003;Se llev&#xf3; a cabo un estudio observacional para determinar los s&#xed;ntomas neurol&#xf3;gicos en el medio y largo plazo tras COVID-19. Una muestra aleatoria de 124 ni&#xf1;os se diagnostic&#xf3; por tests de saliva. Los tests para COVID-19 pod&#xed;an ser negativos o positivos, en ni&#xf1;os sintom&#xe1;ticos o asintom&#xe1;ticos.</AbstractText><AbstractText Label="RESULTADOS" NlmCategory="RESULTS">&#x2003;Los s&#xed;ntomas neurol&#xf3;gicos se evaluaron entre 6 y 12 meses y 2 a&#xf1;os posinfecci&#xf3;n. Se observaron s&#xed;ntomas agudos como cefalea, anosmia, ageusia y mialgias en m&#xe1;s del 20% de los ni&#xf1;os, que generalmente se resolvieron en un plazo de 6 a 12 meses. En el 3% de los casos, se informaron dificultades funcionales persistentes, como para estudiar, prestar atenci&#xf3;n y socializar. Los s&#xed;ntomas conductuales se produjeron en el 7.8% en el momento inicial, pero remitieron en la mayor&#xed;a de los casos, excepto en aquellos con afectaci&#xf3;n previa. CONCLUSI&#xf3;N: &#x2003;Estos hallazgos enfatizan la necesidad del monitoreo continuo de ni&#xf1;os tras la infecci&#xf3;n por COVID-19 y la importancia de intervenciones de salud personalizadas.</AbstractText><CopyrightInformation>The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution 4.0 International License, permitting copying and reproduction so long as the original work is given appropriate credit (https://creativecommons.org/licenses/by/4.0/).</CopyrightInformation></OtherAbstract><CoiStatement>The authors have no conflict of interest to declare.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>9</Month><Day>25</Day><Hour>4</Hour><Minute>20</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>9</Month><Day>25</Day><Hour>4</Hour><Minute>19</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>24</Day><Hour>18</Hour><Minute>52</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39317224</ArticleId><ArticleId IdType="doi">10.1055/s-0044-1789224</ArticleId></ArticleIdList></PubmedData></PubmedArticle></PubmedArticleSet>